MLchartDataset catalogue

oral myoma vaccine V3-myoma

Term · Oncology and biomedicine · MLC-T-ONC-015699

An orally available therapeutic myoma vaccine containing pooled antigens derived from hydrolyzed, inactivated blood and tumor tissue samples from patients with uterine myoma, with potential antineoplastic and immunomodulatory activities. Upon oral administration, V3-myoma may stimulate the immune system to mount a cytotoxic T-lymphocyte-mediated response against cells expressing myoma-associated antigens. This may reduce the myoma growth and improve myoma-related symptoms.

Table 1. Record
IdentifierMLC-T-ONC-015699
FieldOncology and biomedicine
SynonymsV3-myoma; V3 myoma; V3-myoma vaccine; V3 myoma vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015699",
  "term": "oral myoma vaccine V3-myoma",
  "field": "Oncology and biomedicine",
  "definition": "An orally available therapeutic myoma vaccine containing pooled antigens derived from hydrolyzed, inactivated blood and tumor tissue samples from patients with uterine myoma, with potential antineoplastic and immunomodulatory activities. Upon oral administration, V3-myoma may stimulate the immune system to mount a cytotoxic T-lymphocyte-mediated response against cells expressing myoma-associated antigens. This may reduce the myoma growth and improve myoma-related symptoms.",
  "synonyms": [
    "V3-myoma",
    "V3 myoma",
    "V3-myoma vaccine",
    "V3 myoma vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/oral-myoma-vaccine-v3-myoma/"
}

Record 12,324 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.